Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 3,000 shares at $48.76 ($147K) on 2018-02-15, disclosed to the SEC on 2018-02-16.
Open-market sale of $147k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.76 | 1,400 | $68K | 46.4% |
| 2 | $49.20 | 1,600 | $79K | 53.6% |
| Total | $48.99 avg | 3,000 | $147K | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |